6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma" A Duke and UTSW Collaboration

Administered By

Awarded By

Contributors

Start/End

  • September 13, 2021 - August 31, 2026